All Updates

All Updates

icon
Filter
Product updates
WellTheory launches enterprise solution for autoimmune care
Preventive Healthcare
Oct 3, 2023
This week:
Product updates
Meta introduces Meta Credits digital currency for Horizon Worlds
Metaverse Platforms
Today
Product updates
Liquid AI launches STAR framework for AI model architecture optimization
Foundation Models
Today
Funding
9fin raises USD 50 million in Series B funding to expand US operations
Capital Markets Tech
Yesterday
Partnerships
Shastic partners with MeridianLink to provide AI workflow automation for financial institutions
Workflow Automation Platforms
Yesterday
Funding
KisoJi Biotechnology raises CAD 41 million to develop oncology candidate
AI Drug Discovery
Yesterday
M&A
Deel acquires UK money transfer startup Atlantic Money for undisclosed sum
Remote Work Infrastructure
Yesterday
Funding
Acorai raises EUR 4.2 million in funding to advance clinical studies
Next-gen Medical Devices
Yesterday
Product updates
Bosch announces Light Drive, an AR solution for all-day smart glasses
Extended Reality
Yesterday
Product updates
Partnerships
Vuzix expands OSHA collaboration; launches upgraded M400 AR smart glasses
Extended Reality
Yesterday
Product updates
StrikerVR launches pre-orders for consumer-facing Mavrik haptic VR gun
Extended Reality
Yesterday
Preventive Healthcare

Preventive Healthcare

Oct 3, 2023

WellTheory launches enterprise solution for autoimmune care

Product updates

  • Chronic care management startup WellTherory has launched an enterprise solution aimed at employers and payers for autoimmune care. The platform tackles the hidden costs and productivity impacts of untreated autoimmune diseases.

  • The company’s enterprise solution is a virtual care platform that addresses the underlying causes of autoimmunity and provides whole-body care, including community-based programs. It integrates into an enterprise's existing ecosystem and offers tailored support for employers and payers.

  • Since its launch in November 2022 , WellTheory claims its direct-to-consumer solution has recorded an 85% reduction in fatigue, a 53% decrease in pain, and a 74% increase in overall life satisfaction within 20 weeks. Additionally, it has led to healthcare cost savings, with an 85% decrease in ER and urgent care visits within 16 weeks and estimated annual savings of over USD 11,000 per member on biologics.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.